KS

Kazumi Shiosaki

Managing Director at MPM Capital

Boston, Massachusetts

Overview

Work Experience

MC

MPM Capital

  • Managing Director

    - Current

Epizyme

  • CEO

    2007 - 2010

Primera

  • CEO

    2004 - 2006

MP

Millennium Pharmaceuticals

  • SVP Drug Discovery

    1997 - 2001

Education

Investments

Twentyeight-Seven Therapeutics

Series A

Total Funding: $80M

Epizyme

Series B

Total Funding: $45M

Relevant Websites